Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the ...
VeracyteVCYT opened its doors with a simple theory: Not all cancer patients need surgery or chemotherapy. In fact, for some, these treatments could make their outcomes worse. Today, the South San ...
President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...
A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer. Instead of simply shrinking tumors, the experimental medicine appears to ...
Hosted on MSN
New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new test could make it easier to detect high-risk prostate cancer cases earlier. The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results